Belite Bio (BLTE) Research & Development (2022 - 2026)

Belite Bio's Research & Development history runs 5 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• On a quarterly basis, Research & Development rose 66.68% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $36.0 billion, a 55.26% increase from a year earlier, with the FY2025 full-year figure at $45.4 million, up 51.56% from the prior year.
• Research & Development slipped to $15.7 million in Q1 2026 per BLTE's latest filing, from $14.6 billion in the prior quarter.
• Across five years, Research & Development topped out at $14.6 billion in Q4 2025 and bottomed at $4.9 million in Q4 2023.
• The 5-year median for Research & Development is $5.6 billion (2023), against an average of $5.0 billion.
• Across the five-year window, Research & Development jumped 149097.86% in 2024 and slumped 99.86% in 2025, its largest moves.
• Year by year, Research & Development stood at $5.2 million in 2022, then dropped by 6.97% to $4.9 million in 2023, then soared by 149097.86% to $7.3 billion in 2024, then jumped by 101.6% to $14.6 billion in 2025, then slumped by 99.89% to $15.7 million in 2026.
• Per Business Quant, the three latest BLTE Research & Development figures stand at $15.7 million (Q1 2026), $14.6 billion (Q4 2025), and $10.3 billion (Q3 2025).